Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 201

The DOI matches its Crossref record.

Brain Amyloid Imaging — FDA Approval of Florbetapir F18 Injection

Yang, Lucie, Rieves, Dwaine, Ganley, Charles·2012·New England Journal of Medicine

Abstract

The FDA has approved a new radiopharmaceutical agent to assist in detecting causes of cognitive impairment other than Alzheimer's disease. But unique features of imaging information obtained with florbetapir F18 injection require careful consideration in diagnosis.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1056/nejmp1208061

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

No references could be resolved yet.

Research works printed but not linked: 2

  1. 10.1056/NEJMp1107288 · DOI
  2. 10.1053/j.semnuclmed.2011.03.001 · DOI

Cited by

See all 201

Metadata

Authors
Yang, L., Rieves, D., & Ganley, C.
Venue
New England Journal of Medicine
Published
2012-09-06
Volume
367
Issue
10
Pages
885-887
ISSN
  • 0028-4793 (ISSN-L)
  • 1533-4406
OpenAlex
W2088459134
Cited by
201
References
0
FWCI
15.58
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Brain Amyloid Imaging — FDA Approval of Florbetapir F18 Injection. https://app.cochat.ai/papers/10.1056/nejmp1208061
The paper
Yang, L., Rieves, D., & Ganley, C. (2012). Brain Amyloid Imaging — FDA Approval of Florbetapir F18 Injection. New England Journal of Medicine. https://doi.org/10.1056/nejmp1208061

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.